Skip to main content
Article thumbnail
Location of Repository

Differences in costs of and access to pharmaceutical products in the EU

By Panos Kanavos, Sotiris Vandoros, Rachel Irwin, Elena Nicod and Margaret Casson

Abstract

This report reviews the differences in the prices of pharmaceuticals among Member States. It presents an overview of the prices for pharmaceuticals protected by patents as well as those for off-patent pharmaceuticals subject to competition from lower-priced “generic” versions. The report reviews the approaches that Member States have used to regulate the pharmaceutical market on both the supply and demand sides, and assesses evidence regarding the impact of these different approaches on pharmaceutical prices, costcontainment, industry innovation. The report also considers the implications for patient access to pharmaceuticals. The report considers policy options to strengthen coordination among Member States and exchange best practice

Topics: RA Public aspects of medicine, RS Pharmacy and materia medica
Publisher: European Parliament
Year: 2011
OAI identifier: oai:eprints.lse.ac.uk:41732
Provided by: LSE Research Online
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www2.lse.ac.uk/business... (external link)
  • http://eprints.lse.ac.uk/41732... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.